Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Nkarta, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
CTI BIOPHARMA CORPListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
CTI BIOPHARMA CORPListing unverified | Other | $35.1K | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $413 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $885 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $375.2 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $118 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $649 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $767 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $413 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $732 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $540 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $498 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $236 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $295 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $354 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $5.8K | Unusual size | SEC | |
CTI BIOPHARMA CORPListing unverified | Sell | $696 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $3.5K | Unusual size | SEC | |
CTI BIOPHARMA CORPListing unverified | Sell | $819 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $456 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $372 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $984 | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $2.1K | SEC | ||
CTI BIOPHARMA CORPListing unverified | Sell | $2.3K | SEC |